Mitsubishi UFJ Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247K | Buy |
6,783
+441
| +7% | +$16K | ﹤0.01% | 953 |
|
|
2025
Q1 | $230K | Buy |
6,342
+493
| +8% | +$17.9K | ﹤0.01% | 943 |
|
|
2024
Q4 | $243K | Sell |
5,849
-712
| -11% | -$29.5K | ﹤0.01% | 963 |
|
|
2024
Q3 | $364K | Sell |
6,561
-613
| -9% | -$34.1K | ﹤0.01% | 895 |
|
|
2024
Q2 | $295K | Buy |
7,174
+1,123
| +19% | +$46.2K | ﹤0.01% | 920 |
|
|
2024
Q1 | $283K | Sell |
6,051
-274
| -4% | -$12.8K | ﹤0.01% | 923 |
|
|
2023
Q4 | $303K | Buy |
6,325
+757
| +14% | +$36.3K | ﹤0.01% | 971 |
|
|
2023
Q3 | $198K | Buy |
5,568
+79
| +1% | +$2.82K | ﹤0.01% | 1023 |
|
|
2023
Q2 | $253K | Sell |
5,489
-2,328
| -30% | -$107K | ﹤0.01% | 1007 |
|
|
2023
Q1 | $313K | Buy |
7,817
+468
| +6% | +$18.8K | ﹤0.01% | 977 |
|
|
2022
Q4 | $335K | Buy |
7,349
+2,061
| +39% | +$93.8K | ﹤0.01% | 971 |
|
|
2022
Q3 | $219K | Buy |
5,288
+9
| +0.2% | +$373 | ﹤0.01% | 1013 |
|
|
2022
Q2 | $315K | Buy |
5,279
+1,387
| +36% | +$82.8K | ﹤0.01% | 990 |
|
|
2022
Q1 | $283K | Buy |
3,892
+225
| +6% | +$16.4K | ﹤0.01% | 1005 |
|
|
2021
Q4 | $309K | Buy |
3,667
+922
| +34% | +$77.7K | ﹤0.01% | 1003 |
|
|
2021
Q3 | $248K | Hold |
2,745
| – | – | ﹤0.01% | 1030 |
|
|
2021
Q2 | $262K | Sell |
2,745
-435
| -14% | -$41.5K | ﹤0.01% | 1055 |
|
|
2021
Q1 | $362K | Buy |
3,180
+1,068
| +51% | +$122K | ﹤0.01% | 931 |
|
|
2020
Q4 | $292K | Sell |
2,112
-586
| -22% | -$81K | ﹤0.01% | 913 |
|
|
2020
Q3 | $222K | Buy |
2,698
+38
| +1% | +$3.13K | ﹤0.01% | 887 |
|
|
2020
Q2 | $208K | Sell |
2,660
-2,014
| -43% | -$157K | ﹤0.01% | 889 |
|
|
2020
Q1 | $208K | Buy |
4,674
+835
| +22% | +$37.2K | ﹤0.01% | 848 |
|
|
2019
Q4 | $165K | Buy |
3,839
+1,309
| +52% | +$56.3K | ﹤0.01% | 903 |
|
|
2019
Q3 | $108K | Buy |
2,530
+503
| +25% | +$21.5K | ﹤0.01% | 896 |
|
|
2019
Q2 | $129K | Sell |
2,027
-276
| -12% | -$17.6K | ﹤0.01% | 891 |
|
|
2019
Q1 | $160K | Buy |
2,303
+379
| +20% | +$26.3K | ﹤0.01% | 821 |
|
|
2018
Q4 | $77K | Buy |
1,924
+274
| +17% | +$11K | ﹤0.01% | 878 |
|
|
2018
Q3 | $126K | Buy |
+1,650
| New | +$126K | ﹤0.01% | 826 |
|